Nutriband Inc. (NTRB) NASDAQ
3.73
+0.1(+2.75%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.73
+0.1(+2.75%)
Currency In USD
| Previous Close | 3.63 |
| Open | 3.61 |
| Day High | 3.74 |
| Day Low | 3.57 |
| 52-Week High | 11.68 |
| 52-Week Low | 3.42 |
| Volume | 5,454 |
| Average Volume | 13,813 |
| Market Cap | 45.41M |
| PE | -1.22 |
| EPS | -3.05 |
| Moving Average 50 Days | 4.16 |
| Moving Average 200 Days | 5.88 |
| Change | 0.1 |
Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica
GlobeNewswire Inc.
Feb 17, 2026 12:00 PM GMT
ORLANDO, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. today announced that it has signed an exclusive distribution agreement with Costa Rica Based Innomedica for AVERSA Fentanyl upon approval and all sports tape products manufactured at i
Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points
GlobeNewswire Inc.
Jan 30, 2026 12:00 PM GMT
ORLANDO, Fla., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) has provided an update to shareholders on the key milestones and discussions from this years Annual Shareholders Meeting, held on Jan 24, 2026 in Orlando
Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio
GlobeNewswire Inc.
Dec 29, 2025 2:00 PM GMT
Earthvision Bio, is currently developing and commercializing its line of sustainable products developed by Dr. Gordon Moore, the founder of Intel, and Dr. Hans Franke, ex-chairman for Chevron Europe Nutriband Inc. Shareholders will retain 10% of the